CorVel grows revenue 7% to $959M, boosts buybacks 49%, warns of AI-driven cyber threats

Filed May 22, 2026 · Period ending March 31, 2026 · Compared to 10-K May 23, 2025 · ~1 min read

Key Changes

• high

  Revenue growth decelerated to 7% ($959M) from 13% prior year, driven by existing customer expansion in higher-margin network solutions (up 15%) while patient management growth slowed sharply to 3% from 10%.

  MD&A: Revenue & Segment Performance verify on EDGAR →
• high

  Share repurchases surged 49% to $56.2M (783K shares at avg $71.81), more than double prior year's share count, reflecting lower stock price and management confidence despite revenue deceleration.

  MD&A: Capital Allocation verify on EDGAR →
• high

  New CFO Brian S. Nichols appointed effective September 10, 2025, marking key executive transition in financial leadership.

  Business: CFO Appointment verify on EDGAR →